Latest market price
3.14
+0.08+2.61%
OverviewShort InterestFilings
LXEOQT11Lexeo Therapeutics, Inc. Common Stock·NASDAQ
3.14+2.61%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 2026S-3Shelf registration statement
Oct 13, 2026SC 13GBeneficial ownership statement (passive)
Sep 29, 20268-KCurrent report
Sep 28, 20264Statement of changes in beneficial ownership
Sep 28, 20264Statement of changes in beneficial ownership
Sep 28, 20264Statement of changes in beneficial ownership
Sep 28, 20264Statement of changes in beneficial ownership
Sep 22, 20268-KCurrent report
Aug 19, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 18, 2026144Notice of proposed sale of restricted securities
Aug 18, 2026144Notice of proposed sale of restricted securities
Aug 18, 2026144Notice of proposed sale of restricted securities
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 202610-QQuarterly report
Aug 12, 20268-KCurrent report
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 2026144Notice of proposed sale of restricted securities
Jul 01, 2026144Notice of proposed sale of restricted securities
Jul 01, 2026144Notice of proposed sale of restricted securities
#1 / 25 of 360
Page
▼
/ 15